Enhanced Disease Severity inHelicobacter pylori-Infected Mice Deficient in Fas Signaling
Open Access
- 1 May 2002
- journal article
- research article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 70 (5), 2591-2597
- https://doi.org/10.1128/iai.70.5.2591-2597.2002
Abstract
Recent evidence suggests that immune-mediated gastric epithelial cell apoptosis through Fas-Fas ligand interactions participates in Helicobacter pylori disease pathogenesis. To define the role of Fas signaling in vivo, H. pylori strain SS1 infection in C57BL/6 mice was compared to that in mice deficient in the Fas ligand (gld). gld mice had a degree of gastritis similar to that of C57BL/6 mice after 6 weeks (gastritis score, 5.2 ± 0.6 [mean ± standard error] versus 3.5 ± 0.8) and 12 weeks (4.0 ± 0.7 versus 3.4 ± 0.5) of infection. Bacterial colonization was comparable in each group of mice at 12 weeks of infection (2.1 ± 0.3 versus 1.6 ± 0.3 for gld and C57BL/6, respectively; the difference is not significant). Sixty-seven percent of H. pylori-infected gld mice displayed atrophic changes in the gastric mucosa, compared with 37% of infected C57BL/6 mice, at 12 weeks. In addition, atrophic changes were more severe in H. pylori-infected gld mice (P < 0.05). Splenocytes isolated from H. pylori-infected C57BL/6 mice had a twofold increase in production of the Th1 cytokine gamma interferon (IFN-γ) in response to H. pylori antigens at both 6 and 12 weeks compared to controls (143 ± 65 versus 69 ±26 pg/ml and 336 ± 73 versus 172 ± 60, respectively). In contrast, there was a lack of detectable IFN-γ in gld mice infected with the bacterium. H. pylori-infected C57BL/6 mice had increased epithelial cell apoptosis compared with sham-infected C57BL/6 mice (35.0 ± 8.9 versus 12.3 ± 6.9; P < 0.05). Epithelial cell apoptosis did not differ between H. pylori-infected and control gld mice (5.2 ± 1.6 versus 6.5 ± 2.9 [not significant]). These data demonstrate that mice with mutations in the Fas ligand develop more severe premalignant mucosal changes in response to infection with H. pylori in association with both an impaired gastric epithelial cell apoptotic response and IFN-γ production. The Fas death pathway modulates disease pathophysiology following murine infection with H. pylori. Deregulation of the Fas pathway could be involved in the transition from gastritis to gastric cancers during H. pylori infection.Keywords
This publication has 45 references indexed in Scilit:
- CD95/CD95 Ligand Interactions on Epithelial Cells in Host Defense to Pseudomonas aeruginosaScience, 2000
- In Vivo Disruption of the Fas Pathway Abrogates Gastric Growth Alterations Secondary toHelicobacterInfectionThe Journal of Infectious Diseases, 2000
- Involvement of the CD95 (APO-1/Fas) receptor and ligand system in Helicobacter pylori-induced gastric epithelial apoptosis.Journal of Clinical Investigation, 1998
- Death Receptors: Signaling and ModulationScience, 1998
- The Effect of Class II Major Histocompatibility Complex Expression on Adherence of Helicobacter pylori and Induction of Apoptosis in Gastric Epithelial Cells: A Mechanism for T Helper Cell Type 1–mediated DamageThe Journal of Experimental Medicine, 1998
- Expression of Fas Antigen and Its Mediation of Apoptosis in Human Gastric Cancer Cell LinesJapanese Journal of Cancer Research, 1997
- A possible involvement of Fas-Fas ligand signaling in the pathogenesis of murine autoimmune gastritisGastroenterology, 1996
- Induction of gastric epithelial apoptosis by Helicobacter pylori.Gut, 1996
- Fas and the art of lymphocyte maintenance.The Journal of Experimental Medicine, 1996
- Fas and Fas ligand: lpr and gld mutationsImmunology Today, 1995